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a  b  s  t  r  a  c  t
Extensive  consumer  exposure  to food-  and  cosmetics-related  consumer  products  containing  nanosilver
is of public  safety  concern.  Therefore,  there  is a need  for  suitable  in  vitro models  and  sensitive  predictive
rapid  screening  methods  to assess  their  toxicity.  Toxicogenomic  proﬁle  showing  subtle  changes  in  gene
expressions  following  nanosilver  exposure  is  a sensitive  toxicological  endpoint  for  this  purpose.  We  eval-
uated the  Caco2  cells  and  global  gene  expression  proﬁles  as tools  for  predictive  rapid  toxicity  screening
of  nanosilver.  We  evaluated  and  compared  the  gene  expression  proﬁles  of  Caco-2  cells  exposed  to  20  nm
and 50  nm  nanosilver  at a  concentration  2.5 g/ml.  The  global  gene  expression  analysis  of Caco2  cells
exposed  to 20  nm  nanosilver  showed  that  a total of 93  genes  were  altered  at 4 h  exposure,  out of which
90  genes  were  up-regulated  and  3  genes  were  down-regulated.  The  24  h  exposure  of  20  nm  silver altered
15  genes  in  Caco2  cells,  out  of which  14 were  up-regulated  and one  was  down-regulated.  The  most
pronounced  changes  in  gene  expression  were  detected  at 4 h.  The  greater  size  (50  nm)  nanosilver  at  4  hlobal gene expression proﬁles
aco2 cells
exposure  altered  more  genes  by  more  different  pathways  than  the  smaller  (20  nm)  one.  Metallothioneins
and  heat  shock  proteins  were  highly  up-regulated  as  a  result  of  exposure  to both  the  nanosilvers.  The
cellular  pathways  affected  by  the nanosilver  exposure  is  likely  to lead  to increased  toxicity.  The  results
of  our  study  presented  here  suggest  that  the  toxicogenomic  characterization  of  Caco2  cells  is  a valuable
in  vitro  tool  for  assessing  toxicity  of  nanomaterials  such  as  nanosilver.
Published  by  Elsevier  Ireland  Ltd.  This  is  an  open  access  article  under  the  CC BY-NC-ND  license. Introduction
An exponential increase in the use of nanomaterials in con-
umer products has been reported in recent years. The human
xposure to these products is rapidly expanding and, therefore,
heir potential for adverse health effects is of concern. The silver
anoparticles show a wide spectrum of antibacterial and antifun-
al properties [20,42,52]. Therefore, nanosilver is one of the most
ommonly used nanomaterials in consumer products. However, in
pite of their widespread use, very limited information is available
n their potential toxicity. Use of nanosilver in food, food contact
aterials, and dietary supplements has signiﬁcantly increased in
ecent years [53]. Thus, the use of food-related nanosilver is highly
elevant for human exposure [53], and its toxicity screening is nec-
ssary to better ensure the consumer safety.
Ingestion is a major route of human exposure of food-related
anoparticles. It has been reported that the nanoparticles present
∗ Fax: +1 301 210 4600.
E-mail address: saura.sahu@fda.hhs.gov
ttp://dx.doi.org/10.1016/j.toxrep.2016.01.012
214-7500/Published by Elsevier Ireland Ltd. This is an open access article under the CC B(http://creativecommons.org/licenses/by-nc-nd/4.0/).
in gastrointestinal tract play an important role in the develop-
ment of colon disease [54]. The epithelium of the small intestine
and colon provide protection against toxicants in the blood stream
[55]. The epithelial cells separate the gastrointestinal tract from the
systemic circulation and prevent the uptake of toxicants from the
bloodstream. Injury to these epithelial cells impairs their protective
function.
Animal studies required for toxicity screening are costly and
time consuming. Therefore, the search for suitable in vitro mod-
els to accurately predict toxicity in vivo is of interest. One of the
important requirements of safety evaluation of a potential toxi-
cant is its reliable and reproducible toxicity information. The costly
and time consuming animal studies and the lack of human data
led to the evaluation of alternative in vitro models for reliable and
reproducible mechanistic information that can be used for risk
assessment. Human cell lines in culture are sensitive tools for high-
throughput toxicity screening and they have the potential to reduce
the use of animals for toxicological testing in the 21st century [27].
The human gastrointestinal epithelial Caco2 cells are widely
used as an in vitro model for traditional chemical toxicity testing,
representing the oral route of exposure. They are well characterized
Y-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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nd show many of the morphological and biochemical character-
stics of small intestine enterocytes [56,57]. Recently, [61] have
emonstrated that the differentiated Caco2 cells closely resemble
he physiological intestinal epithelium. [58] have used the Caco2
ells as an in vitro model for the prediction of intestinal drug absorp-
ion in vivo. Therefore, the Caco2 cells have been successfully used
s a useful in vitro screening tool for toxicity evaluation of com-
ounds [59,60]. Therefore, in this study we evaluated the Caco2
ells to determine if they can be used as an in vitro model for
redictive rapid screening of food-related nanomaterials.
Multicellular organisms react to environmental changes pri-
arily at the cellular level. Genomic responses to toxic exposures
ffer valuable tools for toxicity evaluation of potential toxicants
62]. The gene expression proﬁles provide molecular information
n the cell-toxicant interactions. The cells respond to environ-
ental stress through adaptive stress response pathways. These
athways are activated at signiﬁcantly lower toxicant concentra-
ions than those causing cellular injury detected by conventional
iochemical methods [62]. The toxicogenomic effects of nanoparti-
les at low levels especially below the detection limits of traditional
iochemical endpoints of toxicity are unknown. Therefore, molec-
lar biomarkers such as gene expression changes which can detect
ellular injury at low levels of toxic exposure are of importance.
oxicogenomic endpoints are very useful for detection of early
tages of toxicity that cannot be detected by conventional end-
oints. Toxicogenomics shows subtle changes in gene expression.
dentiﬁcation of differentially expressed genes reveals the molec-
lar mechanisms of toxic exposures. This technology uses DNA
icroarrays to evaluate the effects of potential toxicants at the
olecular level. It allows the analysis of expression of thousands
f genes simultaneously. Toxicogenomic techniques and human
ells in vitro have the potential to reduce the use of animals and
o eliminate the need for interspecies extrapolation [27].
Recently we have reported the cytotoxic and genotoxic effects
f 20 nm and 50 nm nanosilver in HepG2 and Caco2 cells [34–36,38]
nd toxicogenomic effects of these nanosilvers in HepG2 cells [37].
he purpose of the current study presented here was  to determine
f the Caco2 cells and the global gene expression proﬁles can be used
s useful tools for predictive rapid toxicity screening of food-related
anomaterials such as 20 nm and 50 nm nanosilver.
. Materials and methods
.1. Materials
The 20 nm and 50 nm BioPure® silver nanoparticle citrate solu-
ion was purchased from nanoComposix (San Diego, CA). The
uman colon carcinoma Caco2 cells (ATCC HTB-37), were obtained
rom the American Type Culture Collection (ATCC), Manassas, VA.
eep-frozen vials of stock cells were routinely stored in liquid
itrogen freezer. Dulbecco’s modiﬁed Eagle’s medium (DMEM)
lutaMax, Hanks’ balanced salt solution (HBSS), HEPES, phos-
hate buffered saline (PBS), trypsin-EDTA solution and 0.4% trypan
lue solution were purchased from Invitrogen Corporation (Grand
sland, NY). Fetal bovine serum (FBS) was purchased from the
yclone Labs (Logan, UT). The sterile nonpyrogenic polystyrene
ell culture ﬂasks and plates were purchased from Corning (Corn-
ng, NY) and Becton-Dickinson (Franklin Lakes, NJ), respectively. All
ther chemicals were purchased from Sigma–Aldrich Chemical Co.
St. Louis, MO). Buffer RLT, QIAshredder spin column and EZ1 RNA
ell Mini Kit were purchased form Qiagen (Valencia, CA). The RNA
000 Nano Reagent Kit was purchased from Agilent (Santa Clara,
A). The Affymetrix GeneChip 3′ IVT Express Kit was  purchased
rom Affymetrix (Santa Clara, CA).ts 3 (2016) 262–268 263
2.2. Methods
2.2.1. Characterization of nanoparticles
The silver nanoparticles were characterized by the dynamic
light scattering (DLS), transmission electron microscopy (TEM) and
inductively coupled plasma-mass spectrometry (ICP-MS) analysis
as described previously [34,37]. The stock solution of the nanosil-
ver in aqueous 2 mM citrate was stored at 4 ◦C in small aliquots.
The desired concentrations of silver nanoparticles for cell expo-
sures were prepared fresh by diluting the stock solution with the
cell culture medium just before the experiment [63–65,34,35].
2.2.2. Cell culture
Human colon carcinoma Caco2 cells were stored routinely in
small aliquots in liquid nitrogen and the experimental cultures
were prepared from the frozen stock cells and always kept in a sub-
conﬂuent state [66,67,34,35,37]. The cells were cultured in 75 cm2
culture ﬂasks in Dulbecco’s modiﬁed Eagle’s medium (DMEM) with
GlutaMax containing 1.5% glucose and supplemented with 10%
fetal bovine serum, 1% MEM  non-essential amino acids and 10 mM
HEPES buffer [67–70,9,34,35,37] in a saturating humidiﬁed atmo-
sphere of 5% CO2 in air at 37 ◦C. The culture medium was  changed
every 3–4 days. The cultures were used for testing within 10 pas-
sages after the cells were received from the ATCC.
2.2.3. Cytotoxicity assay
The cytotoxicity of 20 nm and 50 nm nanosilver was  determined
ﬂuorometrically by the resazurin (Alamar Blue) reduction assay as
described previously [34,37]. Brieﬂy, cells were seeded in 96-well
plates and treated with varying concentrations (0.5–25.0 g/ml) of
the 20 nm or 50 nm nanosilver, or with the vehicle control (cell cul-
ture medium), for 4 h or 24 h at 37 ◦C, washed with sterile HBSS, and
then incubated with resazurin for 30 min  at 37 ◦C in a plate reader
using the Sigma Resazurin Assay kit. The rate of increase of resoruﬁn
ﬂuorescence was measured at 545 nm excitation and 590 nm emis-
sion. Each concentration was tested with ten replicates. Statistical
analysis of the results was  conducted using one-way ANOVA.
2.2.4. Treatment of cells with nanosilver
When the cells were grown to approximately 70–80% conﬂu-
ence, they were prepared for the experimental procedures. The cells
were washed with Ca- and Mg-free HBSS and harvested from the
75 cm2 culture ﬂasks by 0.05% trypsin-EDTA. A single cell suspen-
sion in the culture medium was  obtained by repeated trituration.
Cell counts and cell viability were determined by trypan blue dye
exclusion using a hemocytometer. A single cell suspension in the
culture medium at an approximate density 1 × 105 cells/ml was
prepared by serial dilution and this stock cell suspension was used
for seeding cells for the study. The cells were seeded in 6-well plates
(3 ml/well) for 24 h before treatment.
On the day of cell exposure the dosing solutions of 20 nm sil-
ver were prepared by serial dilutions of the stock solution in the
cell culture medium immediately before use. The logarithmically
growing cells were treated with the test agents. The cells were
washed once with HBSS and the dosing solutions were added to
the cells. The concentrations of the dosing solution and the time of
exposure were selected to induce minimum toxicity. The cells were
exposed to the nanosilver at a concentration of 2.5 g/ml for 4 h or
24 h at 37 ◦C in a saturating humidiﬁed atmosphere of 5% CO2 in
air. The control cells received an equal volume of the vehicle (cell
culture medium). After exposure the cells were washed with HBSS
and prepared for the global gene expression proﬁle analysis by DNA
microarray.
2  Repor
2
[
(
p
2
t
V
n
f
E
u
f
c
N
W
A
R
a
2
[
G
S
f
w
a
t
w
t
s
t
f
h
g
a
f
h
A
A
w
s
P
a
s
i
w
2
m
T
ﬁ
a
l
p
s
W
p
t
s
t
f64 S.C. Sahu / Toxicology
.2.5. Global gene expression proﬁle analysis by DNA microarray
DNA microarray analysis was performed as described previously
37] using GeneChip® PrimeViewTM human gene expression array
Affymetrix, Santa Clara, CA) following the standard Affymetrix
rotocol.
.2.6. Total RNA isolation and quality assurance
Total RNA was isolated as described previously [66,37]. After
reatment cells were immediately lysed in Buffer RLT (Qiagen;
alencia, CA) supplemented with -mercaptoethanol, homoge-
ized by QIAshredder spin column (Qiagen), and kept in a −80 ◦C
reezer until further processing. Total RNA was isolated on the
Z1 Advanced XL (Qiagen) automated RNA puriﬁcation instrument
sing the EZ1 RNA Cell Mini Kit (Qiagen) following the manu-
acturer’s protocol, including an on-column DNase digestion. RNA
oncentration and purity (260/280 ratio) were measured with the
anoDrop 2000 UV–vis spectrophotometer (NanoDrop Products,
ilmington, DE). Integrity of RNA samples was assessed by the
gilent 2100 Bioanalyzer (Santa Clara, CA) with the RNA 6000 Nano
eagent Kit from the same manufacturer. The threshold of accept-
bility for Bioanalyzer RIN values was ≥8.5 for the RNA samples.
.2.7. DNA microarray analysis
DNA microarray analysis was performed as described previously
37]. Total RNA samples were preprocessed for hybridization to
eneChip PrimeView Human Gene Expression Array (Affymetrix,
anta Clara, CA) using the Affymetrix GeneChip 3′ IVT Express Kit
ollowing the manufacturer’s protocol. In brief, 0.1 g of total RNA
as used to generate ﬁrst strand cDNA using reverse transcriptase
nd a T7-linked oligo(dT) primer. After second strand synthesis,
he double stranded cDNA was then used for in vitro transcription
ith biotinylated UTP and CTP to amplify the product, referred
o as cRNA ampliﬁcation. Subsequent hybridization, wash, and
taining were carried out using the Affymetrix GeneChip Hybridiza-
ion, Wash, and Stain Kit and the manufacturer’s protocols were
ollowed. Brieﬂy, biotinylated target cRNA was fragmented using
eat and Mg2+ to sizes of 35–200 bp. Each fragmented cRNA tar-
et sample (approximately 10 g) was individually hybridized to
 GeneChip PrimeView Human Gene Expression Array at 45 ◦C
or 16 h in Affymetrix GeneChip Hybridization Oven 645. After
ybridization, the array chips were stained and washed using an
ffymetrix Fluidics Station 450. The chips were then scanned on
ffymetrix GeneChip Scanner 3000 7G and the image (.DAT) ﬁles
ere preprocessed using the Affymetrix GeneChip Command Con-
ole (AGCC) software v.4.0 to generate cell intensity (.CEL) ﬁles.
rior to data analysis, all arrays referred to in this study were
ssessed for data quality using the Affymetrix Expression Console
oftware v.1.3 and all quality assessment metrics (including spike-
n controls during target preparation and hybridization) were found
ithin boundaries.
.2.8. Data processing and statistical analysis
Data analysis was carried out as described previously [37] pri-
arily using the U.S. FDA’s ArrayTrack software system [46,47].
he values of individual probes belonging to one probe set in .CEL
les were summarized using the robust multi-array average (RMA)
lgorithm [16] embedded in ArrayTrack, which comprises of convo-
ution background correction, quantile normalization, and median
olish summarization. Differentially expressed genes (DEGs) were
elected using one-way analysis of variance (ANOVA) based on
elch t-test. To improve moderated t-statistics a gene ﬁltering
rocedure, namely I/NI-calls [12], was applied before the Welch
-test to exclude non-informative genes. For the global gene expres-
ion analysis, the control and treated cells were compared by using
he fold change (FC) of every annotated gene, together with their
alse discovery rate (FDR). Genes were considered differentiallyts 3 (2016) 262–268
altered and of potential biological signiﬁcance if FC ≥1.5 and FDR
≤0.05 compared to vehicle controls. The genes were considered
up-regulated if FC ≥1.5 and FDR ≤0.05, and down-regulated if FC
≤1.0.
2.2.9. Function and pathway analysis of differentially expressed
genes
The DEGs were subjected to gene ontology (GO) and path-
way analysis as described previously [37] using the Database for
Annotation, Visualization, and Integrated Discovery (DAVID) [7,14]
to ﬁnd overrepresentations of GO terms in the biological pro-
cess (BP) category at level 5 (GOTERM BP 5) and KEGG pathways.
As background, the Homo sapiens (human) whole genome was
used. Statistical enrichment was  determined using Fisher exact test
p < 0.05 and count threshold ≥5. The statistically enriched GO terms
were grouped and counted after classiﬁcation according to GO Slim
using the freely available web  tool CateGOrizer [13]. Functional and
pathway analysis were also conducted using the online Ingenu-
ity Pathway Analysis (IPA) software (http://www.ingenuity.com/
products/ipa) with default settings to identify biological functions,
canonical pathways, and networks associated with the signiﬁcantly
regulated genes.
3. Results
3.1. Nanosilver characterization
The 20 nm and 50 nm nanosilver used in this study were char-
acterized by DLS, TEM and ICP-MS analysis as described previously
[34,37]. Both the nanosilvers used in our study were stable in the
cell culture medium [34,37] in agreement with the stability report
from another independent laboratory [30] for the citrate-coated
nanosilver. The average size of the silver nanoparticles and the
concentration of the nanosilver solutions were close to the man-
ufacturer provided values [34,37]. The TEM images of nanosilver
particles showed no aggregation or agglomeration [34,37]. The dos-
ing solutions in this study were prepared based on the nanosilver
concentration determined by our analysis.
3.2. Cytotoxicity of nanosilver in Caco2 cells
We  have reported previously the cytotoxic effects of 20 nm and
50 nm nanosilver in Caco2 cells [34,37,38]. The concentrations of
20 nm and 50 nm nanosilver for the global gene expression analy-
sis by DNA microarray was  selected from the results of these studies
[34,37,38]. In this study we selected 2.5 g/ml as exposure concen-
tration at which no signiﬁcant cytotoxicity was  observed in Caco2
cells after 4 h exposure of either nanosilver [37].
3.3. Global gene expression proﬁles following nanosilver exposure
Global gene expression of Caco2 cells following nanosilver expo-
sure was  evaluated by Affymetrix microarrays [37]. The cells were
treated with 2.5 g/ml 20 nm or 50 nm nanosilver for 4 h or 24 h.
Table 1 shows the differentially expressed genes (DEGs) in Caco2
cells induced by exposure to the 20 nm and 50 nm nanosilvers.
The 20 nm nanosilver exposure of Caco2 cells for 4 h resulted in
a signiﬁcantly changed expression of a total of 93 genes (Table 1
and Table S1), out of which 90 genes were up-regulated (FC ≥ 1.5)
and 3 genes down-regulated (FC ≤ 1.0). However, the 24 h exposure
altered only 15 genes, out of which 14 genes were up-regulated
and one gene down-regulated (Tables 1 and S2). In comparison, the
50 nm nanosilver exposure of Caco2 cells for 4 h resulted in a sig-
niﬁcantly changed expression of a total of 189 genes, out of which
184 genes were up-regulated and 5 genes down-regulated (Tables
1 and S3). The 24 h exposure altered only 43 genes, out of which
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Table  1
Global gene expression changes in Caco2 cells induced by 20 nm and 50 nm nanosilver.
Nanosilver exposure period Nanosilver-induced differentially altered genes 20 nm nanosilver 50 nm nanosilver
4 h Total number of altered genes 93 189
Up-regulated genes 90 184
Down-regulated genes 3 5
24  h Total number of altered genes 15 43
Up-regulated genes 14 41
Down-regulated genes 1 2
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bhe gene expression proﬁles of the treated cells were compared with those of the
FDR)  were used for selection of differentially expressed genes. Genes were conside
ompared to vehicle controls. The genes were considered up-regulated if FC ≥1.5 an
1 genes were up-regulated and 2 genes down-regulated (Tables 1
nd S4).
Fig. 1 shows the Venn diagram of overlapping of the DEGs
etween different treated groups in Caco2 cells. For the 20 nm
anosilver, 12 genes regulated after 24 h exposure were also found
n the genes regulated after 4 h exposure. These genes were mem-
ers of the metallothionein (MT) and heat shock (HSPA) family. For
he 50 nm nanosilver, 27 genes were shared by the two time points.
hese genes were also members of the MT  and HSPA family. The
Ts  and HSPAs were the most affected genes in Caco2 cells exposed
o both 20 nm and 50 nm nanosilver.
.4. Identiﬁcation of biological functions and pathways affected
y nanosilver exposure
Potential mechanisms of nanosilver toxicity in Caco2 cells were
valuated by the gene ontology (GO) and pathway analysis of DEGs
sing DAVID. Fig. 2 shows the GO function classiﬁcation by evalu-
ting the distribution of GO terms for the genes identiﬁed in Caco2
ells exposed to 20 nm and 50 nm nanosilver for 4 h. Only the data
f 4 h exposure with the two nanosilvers were analyzed because
ther conditions did not yield adequate number of DEGs for anal-
sis. Using the CateGOrizer tool, these GO terms for the 20 nm
anosilver were grouped into 6 categories of the pre-deﬁned set
f parent/ancestor GO terms (Fig. 2): metabolism (50%), cell death
42%), biosynthesis (33%), nucleic acid metabolism (17%) and pro-
ein metabolism (9%). For the 4 h exposure to the 50 nm nanosilver
he GO terms were grouped into 15 categories (Fig. 2): metabolism
34%), cell death (19%), communication (11%), development (11%),
iosynthesis (8%), morphogenesis (8%), signal transduction (7%),
ucleic acid metabolism (7%), cell proliferation (4%) and cell home-
statis (2%).
The pathways, enriched in DEGs in Caco2 cells exposed for 4 h
o 20 nm and 50 nm nanosilver, were analyzed by DAVID. The DEGs
ssociated with the 20 nm nanosilver showed the MAPK signaling
athway (Table S5). The DEGs associated with the 50 nm nanosilver
howed three pathways: the MAPK signaling, p53 signaling and
ocal adhesion pathways (Table S6). The MAPK signaling (Fig. S1)
as the common pathways associated with both 20 nm and 50 nm
anosilvers. The p53 Signaling (Fig. S2) and Focal adhesion (Fig. S3)
athways were associated with the 50 nm nanosilver only.
. Discussion
Recently we have reported the toxicogenomic response of the
uman liver HepG2 cells to 20 nm and 50 nm nanosilver using
lobal gene expression proﬁling determined by DNA microarray
37]. In the present study we evaluated genomic changes, induced
y 20 nm and 50 nm nanosilver in human gastrointestinal Caco2
ells, using the same experimental conditions and toxicogenomic
ndpoint to determine if these gastrointestinal epithelial cells can
e used as an in vitro model representing the oral exposure tool cells. The fold change (FC) of the annotated genes and their false discovery rate
fferentially altered and of potential biological signiﬁcance if FC ≥1.5 and FDR ≤0.05
 ≤0.05, and down- regulated if FC ≤1.0.
nanosilver for rapid predictive toxicity screening. The cells were
exposed to the nanosilver at the same dose, 2.5 g/ml, a concen-
tration that showed no cell viability loss after 4 h exposure [37].
Our results presented here (Table 1) show that exposure for 4 h to
the 50 nm nanosilver induced higher number of DEGs (189 genes)
than to the 20 nm nanosilver (93 genes), suggesting that the larger
size nanosilver was  more toxic than the smaller one. This obser-
vation is opposite of what we  observed in HepG2 cells under the
same experimental conditions and genotoxic endpoint, showing
that the smaller 20 nm nanosilver was more toxic than the larger
50 nm one [37]. These results suggest that cell types inﬂuence the
toxicity of nanosilver. After 24 h only 15 DEGs remained after expo-
sure to 20 nm nanosilver and 43 genes following the exposure to
50 nm nanosive (Table 1), suggesting the cellular repair mechanism
that had taken effect in response to the toxic insult exerted by
the nanosilvers. Only a small portion of genes was shared by the
two time points (Fig. 1) compared with the total number of genes
suggesting a dynamic nature of the gene expression changes. The
MAPK signaling without transcript evidence for alteration of cellu-
lar repair genes may also indicate the adjustment of cell signaling
after exposure to nanosilver.
Members of the MT  and HSAP family genes were upregulated
at all the conditions studied (Tables S1–S4). MTs  are a family of
low molecular weight, cysteine-rich proteins existing in several
isoforms [15]. The MT  genes have the capacity to bind both physi-
ological and xenobiotic heavy metals through the thiol group of its
cysteine residues [5]. It has been suggested that MTs  may  provide
protection against metal toxicity by being involved in regulation
of physiological metals, that results in protection against oxida-
tive stress [45]. MT  expression has been implicated as a transient
response to many forms of stress or injury providing cytoprotec-
tive action [45]. HSPA genes are a group of proteins induced by
heat shock. Their expression is increased when cells are exposed to
elevated temperatures or other stress [6]. The upregulation of MTs
and HSAPs found in our study suggests that nanosilver exposure
induced cellular stresses and elicited cellular protective responses
in Caco2 cells as they did in HepG2 cells [37]. Several independent
studies [10,19,51,50] reported up regulation of MTs  and HSPAs in
cultured cells after exposure to nanosilver similar to our ﬁndings.
The transient nature of the gene expression changes was also
reﬂected by the fold change of MTs  and HSPAs relative to the con-
trol. At 4 h, the average fold change was  higher than that at 24 h
(Tables S2–S5).
The mechanism(s) of nanosilver toxicity in Caco2 cells could
be proposed from the cellular pathways (Tables S5 and S6). The
nanosilver exposure regulates the MAPK signaling pathway (Fig.
S1). Several HSPA genes involved in the pathway were signiﬁcantly
upregulated by the exposure to both 20 nm and 50 nm nanosil-
vers. The p53 pathway (Fig. S2) is an important signaling pathway
controlling the molecular response to genotoxic stress that may
ultimately lead to cell cycle arrest, apoptosis, and cancer [28].
Under normal conditions, p53 is constitutively expressed, but is
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Caco2
20 nm
50 nm
4 h
24 h
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Fig. 1. Venn diagrams showing overlap of differentially expressed genes between different experiment groups. The total number of differentially expressed genes in each
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croup  is included in the parentheses under the group name. The fold change (FC)
ifferentially expressed genes. Genes were considered differentially altered and of
he  genes were considered up-regulated if FC ≥ 1.5 and FDR ≤ 0.05, and down- regu
nactivated by its negative regulator, Mdm2.  Upon DNA damage or
ther cellular stresses, various pathways will lead to the dissocia-
ion of the p53 and Mdm2  complex. It has been demonstrated that
enotoxic stress activates the p53 gene [2] and the p53 pathway
lays an important role in genotoxicant-induced cell apoptosis [71].
herefore, the p53 signaling pathway and apoptosis may  be associ-
ted with the genotoxicity of nanosilver in Caco2 and HepG2 cells
34,35]. Once activated, p53 will induce a cell cycle arrest to allow
ither repair of DNA damage or apoptosis to discard the damaged
ell. Failure to do this may  result in cell survival with damaged DNA.
his may  cause further tumerigenesis leading to cancer. When this
tudy was in progress another toxicogenomic study on the effects
f nanogold in Caco2 cells, similar to our nanosilver study, has been
ublished [3] with similar results as ours.
An alternate interpretation of our results could be that the
anosilver might induce a generalized cellular metal response
y primarily upregulating metallothionein (MT) and heat shock
rotein (HSP) transcripts, mediated by MAPK signaling [25,18].
im et al. [25] evaluated by DNA microarray the effects of
anosilver of varying sizes from 5 to 100 nm at sub-lethal concen-
rations in a macrophage cell line. They screened a total of 28,000
DNA proﬁles. They observed a signiﬁcant increase in levels ofe annotated genes and their false discovery rate (FDR) were used for selection of
tial biological signiﬁcance if FC ≥ 1.5 and FDR ≤ 0.05 compared to vehicle controls.
if FC ≤ 1.0.
hemeoxygenase-1 (HO-1), heat shock protein-70 (HSP-70) and
interleukin-8 (IL-8). Kaur and Tikoo [18] examined toxicity of sil-
ver nanoparticles in different cell types (lung epithelial A549, skin
epithelial A431, and murine macrophages RAW264.7) over a range
of concentrations (5–100 g/ml). They reported increased expres-
sion of stress markers HSP-70, pp38MAPK, and TNF-.
We also recognize a “data gap” as a need to provide conﬁrma-
tion and further support of our results by undertaking additional
RT-PCR studies to validate the expression of some of the highly
differentially regulated genes observed in our studies.
The results of the current study suggest that nanosilver exposure
has the potential to cause carcinogenicity. Numerous in vitro stud-
ies have revealed that nanosilver induces genotoxicity in various
cell types [24]. Recently, in vivo genotoxicity and carcinogenicity of
nanosilver were also reported. One study by Xu et al. [49] reported
that nanosilver-hydrogel induced micronuclei, nuclei disruption,
chromatin concentration and cell apoptosis in rabbit reproductive
organ tissues. On the other hand, study by Kim et al. [23] reported
that there was  no genotoxic effect in rats after 28 days oral exposure
to nanosilver. Kim et al. [21] also reported that no genotoxic effect
in rats after 90 days inhalation of nanosilver. The reasons for the
different ﬁndings in potential genotoxic and carcinogenic risks of
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fig. 2. Distribution of GO terms according to GO slim for the genes identiﬁed in C
umber  of GO terms in each class as a percentage of the total number of unique GO
anoparticles are not known, but are possibly due to differences in
xperimental design, use of different nanomaterials and doses, use
f different animal models, and different targeting organs investi-
ated [4]. In addition, all these in vivo studies were relatively short
onsidering the time needed to observe tumor development in ani-
als. In this regard, it has to be noted that it took over 10 years to
onﬁrm the carcinogenicity of asbestos nanoﬁbers [39]. Therefore
ong-term studies on nanoparticle in vivo toxicity are warranted
n order to gain a better understanding of their genotoxicity and
arcinogenicity.
. Conclusions
This study demonstrates that 20 nm and 50 nm nanosilver inter-
ct with Caco2 cells to induce cellular toxicogenomic responses
hat could be further exploited as biomarkers of nanosilver expo-
ure. The Caco2 cells exposed to nanosilvers responded to the toxic
nsult by upregulating stress response genes such as metalloth-
oneins and heat shock proteins. The cellular pathways affected by
he nanosilver exposure may  lead to increased toxicity. The results
f our study presented here suggest that toxicogenomic character-
zation of human Caco2 cells is a valuable in vitro tool for assessing
oxicities of nanoparticles.
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